E

Edgewise Therapeutics

Develops therapies for rare muscular disorders

Research Associate

Full-TimeUpdated
$60k - $85k+ Discretionary bonus + Stock option grants
Mid
Bachelor of Science (BS)
Portland, OR, USA
In Person
Biology & BiotechTranslational Research & Bench Biology

About the job

Requirements
  • A Bachelor of Science in a scientifically related field is required.
  • At least 2 years of research laboratory experience are required.
  • Familiarity with safe and efficient laboratory practices is required.
  • General scientific computer and software application proficiency is required.
Responsibilities
  • Perform experiments to investigate a specific question or problem in collaboration with a supervisor and/or project team members.
  • Conduct detailed wet laboratory experiments using appropriate techniques and adequate controls to substantiate and replicate results.
  • Coordinate laboratory work with project team objectives.
  • Interpret basic experimental results and draw conclusions for use by the project team.
  • Report organized data, make comparisons, and identify trends.
  • Suggest improvements to laboratory efficiency.
  • Operate laboratory technology related to the assigned project at a high level of competence.
  • Demonstrate basic command of scientific techniques and tools used in the relevant area of science or research.
  • Participate in project team meetings.
  • Maintain scientific records in electronic lab notebooks (ELNs) in the required clear form.
  • Update job knowledge by participating in educational opportunities, reading professional publications, maintaining professional networks, and participating in professional organizations.
  • Read, understand, and comply with workplace health and safety policies, safe work practices, and company policies and procedures.
  • Perform other duties as assigned by the supervisor.

About the company

Edgewise Therapeutics develops therapies for rare muscle disorders using a proprietary drug discovery platform. Its lead molecule, sevasemten (EDG 5506), targets the muscle motor protein myosin to reduce stress in fast skeletal muscle fibers, aiming to improve muscle health without affecting other muscle types. The company owns global development and commercialization rights to its programs and pursues strategic collaborations and asset acquisitions to accelerate its pipeline. Its focus is precision medicine for conditions like Duchenne muscular dystrophy, Becker muscular dystrophy, Limb Girdle muscular dystrophies, and McArdle disease. Overall, Edgewise seeks to deliver targeted treatments that protect and improve muscle health for patients and families affected by these rare diseases.

Company Size

51-200

Company Stage

IPO

Headquarters

Boulder, null

Founded

2017

Get referred to Edgewise Therapeutics

See people who can refer or advise you

Benefits

  • Health Insurance
  • 401(k) Company Match
  • Stock Options
  • Employee Stock Purchase Plan